| 发明名称 |
Novel Uses of GLP-1 Receptor Agonists in Patients Treated with Insulin and/or Suffering from Type 1 Diabetes |
| 摘要 |
The present invention relates to GLP-1 receptor agonists for use in hypoglycaemia or hypoglycaemic episodes in patients treated with insulin and/or suffering from type 1 diabetes, e.g. for reducing the number of hypoglycaemia or hypoglycaemic episodes. |
| 申请公布号 |
US2016136246(A1) |
申请公布日期 |
2016.05.19 |
| 申请号 |
US201414899821 |
申请日期 |
2014.06.23 |
| 申请人 |
NOVO NORDISK A/S |
发明人 |
Christiansen Erik |
| 分类号 |
A61K38/26;A61K38/28 |
主分类号 |
A61K38/26 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for reducing the amount of exogenous glucose needed for recovering from hypoglycaemia or a hypoglycaemic episode, comprising administering a GLP-1 receptor agonist to a patient in need thereof
iv). |
| 地址 |
Bagsværd DK |
